Oflox-OZ Syrup 30 ml

babies: safe lactating mothers: nil pregnancy: nil alcohol: nil driving: nil kidney: this syrup should be used with caution in patients with kidney disease. dose adjustment of this syrup may be needed.
please consult your doctor. liver: this syrup should be used with caution in patients with kidney disease. dose adjustment of this syrup may be needed.
please consult your doctor..

Weight loss Abdominal pain Diarrhea Insomnia (difficulty in sleeping) Nausea Vomiting Loss of appetite Dizziness Headache.

OFLOX OZ syrup is an antibiotic. it contains ofloxacin and ornidazole as active ingredients.
both materials forge bacterial dna. this way, it kills the bacteria causing the infection, stopping the infection and bacteria from growing without making them resistant to further treatment..

If you miss a dose of OFLOX OZ, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• diarrhea is a common side effect of OFLOX OZ syrup. encourage your child to drink plenty of water as they thrive • your child may experience a change in taste or a hairy tongue after taking this syrup.
eating citrus fruits or drinking plenty of water or fruit juices can help • do not give calcium, magnesium, iron, vitamins, or antacids within 2 hours of taking this syrup because it can affect the absorption of the drug • diseases such as the common cold and flu are caused by viruses. never use this medicine under such conditions • stop taking this syrup and talk to your doctor right away if your child has a rash, itchy skin, swelling of the face and mouth, or trouble breathing • give this syrup only to your child for their current infection.
never save a cure for a future illness • this syrup has been prescribed to you to treat various bacterial and parasitic infections.

contraindicated • ofloxacin + bepridil: concurrent use may lead to increased risk of qt-interval prolongation • ofloxacin + cisapride: concurrent use may lead to increased risk of qt-interval prolongation • ofloxacin + mesoridazine: concurrent use may lead to increased risk of qt-interval prolongation major • ofloxacin + acarbose: concurrent use may lead to increased risk of hypoglycemia or hyperglycemia • ofloxacin + acecainide: concurrent use may lead to increased risk of cardiotoxicity • ofloxacin + alosetron: concurrent use may lead to increased plasma concentration and half-life of alosetron.